{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T03:08:30Z","timestamp":1789268910913,"version":"build-2803163510"},"reference-count":103,"publisher":"Open Exploration Publishing","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Explor Target Antitumor Ther"],"accepted":{"date-parts":[[2026,7,7]]},"abstract":"<jats:p xml:lang=\"en\">Aim: Breast cancer is the most prevalent malignant tumor among women. Human papillomavirus (HPV) has been detected in breast tumors since the 1990s, and beyond its oncogenic potential, therapy resistance driven by viral immune evasion in non-anogenital tumors, such as oropharyngeal cancers, highlights the need to investigate viral activity in breast tissues. Among high-risk HPV types, HPV16 is one of the most prevalent and exhibits the highest carcinogenic potential. Therefore, this study aimed to evaluate the expression of HPV16 oncogenes E5, E6, and E7 in breast tumors, as well as the modulation of the PI3K\/AKT\/mTOR signaling pathway associated with viral activity. Methods: A total of 92 breast cancer patients were included after Ethics Committee approval. Clinical data were obtained from medical records. RNA was extracted from formalin-fixed, paraffin-embedded tissues and reverse-transcribed into cDNA. Transcripts of HPV oncogenes (E5, E6, and E7), components of the PI3K\/AKT\/mTOR pathway, and regulatory genes (EGFR and PTEN) were quantified by RT-qPCR. Gene expression levels were calculated using the \u0394Ct method. Results: Forty-eight samples met RNA quality criteria and were included in the expression analysis. Among these, 77.08% showed expression of at least one viral oncogene, with E5 being the most frequently expressed. The PI3K\/AKT\/mTOR pathway was modulated in HPV-positive samples, with increased PI3K expression and decreased mTOR expression. Notably, the high expression of E5\u2014associated with immune evasion\u2014combined with reduced mTOR expression suggests that HPV16 status may influence therapeutic response in breast cancer patients. Conclusions: These findings reinforce the importance of further studies investigating HPV activity in breast tumors to better understand its biological and clinical impact.<\/jats:p>","DOI":"10.37349\/etat.2026.1002391","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:52:12Z","timestamp":1785891132000},"update-policy":"https:\/\/doi.org\/10.37349\/open_exploration_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transcriptional modulation of the PI3K\/AKT\/mTOR signaling pathway mediated by HPV16 E5, E6, and E7 oncogene expression in breast cancer"],"prefix":"10.37349","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5757-5058","authenticated-orcid":false,"given":"Beatriz Eda","family":"de Oliveira Is\u00eddio","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Studies and Experimental Therapy, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5609-2977","authenticated-orcid":false,"given":"Pedro Henrique Bezerra","family":"Fontes","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Studies and Experimental Therapy, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4712-4949","authenticated-orcid":false,"given":"Gabriel R\u00f4mulo Parente","family":"da Silva","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Studies and Experimental Therapy, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7286-7007","authenticated-orcid":false,"given":"Stephanie Loureiro","family":"Le\u00e3o","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Studies and Experimental Therapy, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8165-3534","authenticated-orcid":false,"given":"Bianca","family":"de Fran\u00e7a S\u00e3o Marcos","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Studies and Experimental Therapy, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7121-6849","authenticated-orcid":false,"given":"Isabelle Silva","family":"Sim\u00f5es","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Studies and Experimental Therapy, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8005-2588","authenticated-orcid":false,"given":"Elisa Fotin Genn","family":"Barros","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Studies and Experimental Therapy, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4534-4599","authenticated-orcid":false,"given":"David Beltr\u00e1n","family":"Luss\u00f3n","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Studies and Experimental Therapy, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1652-0272","authenticated-orcid":false,"given":"Gabriela Vit\u00f3ria de","family":"Araujo","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Studies and Experimental Therapy, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1501-4478","authenticated-orcid":false,"given":"Isabela Duarte de","family":"Farias","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Studies and Experimental Therapy, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2415-6337","authenticated-orcid":false,"given":"Karina Mayumi Tani Bezerra de","family":"Melo","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Studies and Experimental Therapy, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0260-1543","authenticated-orcid":false,"given":"Nath\u00e1lya Lima de","family":"Queiroz","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Studies and Experimental Therapy, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Maria Souza da","family":"Silva","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Studies and Experimental Therapy, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9505-6119","authenticated-orcid":false,"given":"Vanessa Emanuelle Pereira","family":"Santos","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Studies and Experimental Therapy, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4957-9549","authenticated-orcid":false,"given":"Antonio Carlos de","family":"Freitas","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Studies and Experimental Therapy, Department of Genetics, Federal University of Pernambuco, Recife 50670-901, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21850","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-022-01856-z","article-title":"Myricetin-induced apoptosis in triple-negative breast cancer cells through inhibition of the PI3K\/Akt\/mTOR pathway","volume":"39","author":"Sharma","year":"2022","journal-title":"Med Oncol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1240098","article-title":"Global epidemiology of breast cancer based on risk factors: a systematic review","volume":"13","author":"Roheel","year":"2023","journal-title":"Front Oncol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/1346-8138.16697","article-title":"Recent advances in cutaneous HPV infection","volume":"50","author":"Shimizu","year":"2023","journal-title":"J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-023-05425-0","article-title":"Global prevalence of human papillomavirus-related oral and oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis","volume":"28","author":"Fons\u00eaca","year":"2023","journal-title":"Clin Oral Investig"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17172870","article-title":"Global Prevalence and Modifiers of Human Papillomavirus Positivity in Oral Cavity Cancer: A Systematic Review and Meta-Analysis of Prevalence (1995-2024)","volume":"17","author":"Iraqui","year":"2025","journal-title":"Cancers (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S1470-2045(14)70471-1","article-title":"HPV DNA, E6\/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis","volume":"15","author":"Ndiaye","year":"2014","journal-title":"Lancet Oncol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.gocm.2023.01.001","article-title":"Clinical significance of extended high-risk human papillomavirus genotyping and viral load in cervical cancer and precancerous lesions","volume":"3","author":"Su","year":"2023","journal-title":"Gynecol Obste Cl Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/BF01836955","article-title":"Human papillomavirus in breast cancer","volume":"21","author":"Di","year":"1992","journal-title":"Breast Cancer Res Treat"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.2217\/fon-2021-1158","article-title":"Association of human papillomavirus with breast cancer: a new perspective on an old debate","volume":"18","author":"Purrahman","year":"2022","journal-title":"Future Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1712118","article-title":"The oncogenic role of human papillomavirus in breast cancer: a comprehensive systematic review and meta-analysis","volume":"16","author":"Koishybayeva","year":"2025","journal-title":"Front Microbiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1737189","article-title":"HPV, APOBEC3B, and the origins of breast cancer: a narrative review and perspectives on novel mechanisms","volume":"15","author":"Liu","year":"2026","journal-title":"Front Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s40944-025-01018-9","article-title":"Prevalence and Genotypic Distribution of","volume":"23","author":"Sakhi","year":"2025","journal-title":"Indian J Gynecol Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/1178223421996279","article-title":"Assessment of Human Papillomavirus Infection and Risk Factors in Egyptian Women With Breast Cancer","volume":"15","author":"El-Sheikh","year":"2021","journal-title":"Breast Cancer (Auckl)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3648","DOI":"10.3390\/cimb44080250","article-title":"Presence of Human Papillomavirus DNA in Malignant Neoplasia and Non-Malignant Breast Disease","volume":"44","author":"Maldonado-Rodr\u00edguez","year":"2022","journal-title":"Curr Issues Mol Biol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/cells13131132","article-title":"HPV Detection in Breast Tumors and Associated Risk Factors in Northeastern Brazil","volume":"13","author":"Nascimento","year":"2024","journal-title":"Cells"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e37027","article-title":"Correlation between breast cancer and human papillomavirus (HPV) infection","volume":"10","author":"Zhao","year":"2024","journal-title":"Heliyon"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02083-w","article-title":"Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/biology10080804","article-title":"Human Papillomavirus in Breast Carcinogenesis: A Passenger, a Cofactor, or a Causal Agent?","volume":"10","author":"Blanco","year":"2021","journal-title":"Biology (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.5114\/pjp.2021.113073","article-title":"EGFR\/PI3K\/Akt\/mTOR pathway in head and neck squamous cell carcinoma patients with different HPV status","volume":"72","author":"Janecka-Wid\u0142a","year":"2021","journal-title":"Pol J Pathol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0793-1","article-title":"EGFR-TKIs resistance via EGFR-independent signaling pathways","volume":"17","author":"Liu","year":"2018","journal-title":"Mol Cancer"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2174\/1568026620666200303123102","article-title":"Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors","volume":"20","author":"Sabbah","year":"2020","journal-title":"Curr Top Med Chem"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-025-01119-9","article-title":"EGF receptor in organ development, tissue homeostasis and regeneration","volume":"32","author":"Tito","year":"2025","journal-title":"J Biomed Sci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2017.10.008","article-title":"Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis","volume":"62","author":"Gonzalez-Conchas","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/life14060682","article-title":"Prognostic and Clinical Significance of PD-L1, EGFR and Androgen Receptor (AR) Expression in Triple-Negative Breast Cancer (TNBC) Patients","volume":"14","author":"Medi\u0107-Miliji\u0107","year":"2024","journal-title":"Life (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11010109","article-title":"Targeting PI3K\/AKT\/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges","volume":"11","author":"Cerma","year":"2023","journal-title":"Biomedicines"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78646-y","article-title":"Combination treatment with a PI3K\/Akt\/mTOR pathway inhibitor overcomes resistance to anti-HER2 therapy in PIK3CA-mutant HER2-positive breast cancer cells","volume":"10","author":"Fujimoto","year":"2020","journal-title":"Sci Rep"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1158\/1078-0432.CCR-18-3049","article-title":"The Dual PI3K\/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in","volume":"25","author":"Ippen","year":"2019","journal-title":"Clin Cancer Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1158\/1535-7163.MCT-13-0159","article-title":"Combined targeting of mTOR and AKT is an effective strategy for basal-like breast cancer in patient-derived xenograft models","volume":"12","author":"Xu","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.116850","article-title":"Strategic advancements in targeting the PI3K\/AKT\/mTOR pathway for Breast cancer therapy","volume":"236","author":"Garg","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1186\/s12867-015-0033-9","article-title":"Pre-amplification in the context of high-throughput qPCR gene expression experiment","volume":"16","author":"Korenkov\u00e1","year":"2015","journal-title":"BMC Mol Biol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-2-235","article-title":"RNA pre-amplification enables large-scale RT-qPCR gene-expression studies on limiting sample amounts","volume":"2","author":"Vermeulen","year":"2009","journal-title":"BMC Res Notes"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1373\/clinchem.2016.268953","article-title":"MIQE: A Step Toward More Robust and Reproducible Quantitative PCR","volume":"63","author":"Bustin","year":"2017","journal-title":"Clin Chem"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0377-0427(87)90125-7","article-title":"Silhouettes: A graphical aid to the interpretation and validation of cluster analysis","volume":"20","author":"Rousseeuw","year":"1987","journal-title":"J Comput Appl Math"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.7150\/thno.78091","article-title":"Human papillomavirus E6\/E7 oncoproteins promote radiotherapy-mediated tumor suppression by globally hijacking host DNA damage repair","volume":"13","author":"Bruyere","year":"2023","journal-title":"Theranostics"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103108","article-title":"Human papillomavirus-16 E6 activates the pentose phosphate pathway to promote cervical cancer cell proliferation by inhibiting G6PD lactylation","volume":"71","author":"Meng","year":"2024","journal-title":"Redox Biol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2022.100027","article-title":"RNA Extraction Method Impacts Quality Metrics and Sequencing Results in Formalin-Fixed, Paraffin-Embedded Tissue Samples","volume":"103","author":"Decruyenaere","year":"2023","journal-title":"Lab Invest"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-022-08837-6","article-title":"Results and lessons from dual extraction of DNA and RNA from formalin-fixed paraffin-embedded breast tumor tissues for a large Cancer epidemiologic study","volume":"23","author":"Ondracek","year":"2022","journal-title":"BMC Genomics"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s40291-021-00525-7","article-title":"Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression","volume":"25","author":"Pellegrino","year":"2021","journal-title":"Mol Diagn Ther"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2147\/BCTT.S340741","article-title":"\u201cDiagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now?\u201d","volume":"15","author":"H\u00f6ller","year":"2023","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"412","DOI":"10.5306\/wjco.v5.i3.412","article-title":"Biological subtypes of breast cancer: Prognostic and therapeutic implications","volume":"5","author":"Yersal","year":"2014","journal-title":"World J Clin Oncol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1590\/S0034-89102010000500023","article-title":"Preval\u00eancia de infec\u00e7\u00e3o do colo do \u00fatero pelo HPV no Brasil: revis\u00e3o sistem\u00e1tica","volume":"44","author":"Ayres","year":"2010","journal-title":"Rev Sa\u00fade P\u00fablica"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2026.105477","article-title":"CIRCULATING GENOTYPES OF HUMAN PAPILLOMAVIRUS (HPV) IN BRAZIL: A SYSTEMATIC REVIEW OF THE LITERATURE","volume":"30","author":"Serra","year":"2026","journal-title":"Braz J Infect Dis"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"313","DOI":"10.7196\/samj.6514","article-title":"Age-specific prevalence of cervical human papillomavirus infection and cytological abnormalities in women in Gauteng Province, South Africa","volume":"103","author":"Richter","year":"2013","journal-title":"S Afr Med J"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1002\/ijc.30579","article-title":"Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice","volume":"140","author":"Wentzensen","year":"2017","journal-title":"Int J Cancer"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0298583","article-title":"High rate of high-risk human papillomavirus among benign and breast cancer patients in Ethiopia","volume":"19","author":"Belachew","year":"2024","journal-title":"PLoS One"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.21037\/atm-19-2756","article-title":"Human papilloma virus (HPV) profiles in breast cancer: future management","volume":"8","author":"Islam","year":"2020","journal-title":"Ann Transl Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60050699","article-title":"Association of Human Papilloma Virus, Cytomegalovirus, and Epstein-Barr Virus with Breast Cancer in Jordanian Women","volume":"60","author":"Khasawneh","year":"2024","journal-title":"Medicina (Kaunas)"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2023.109716","article-title":"Advances in molecular mechanism of HPV16 E5 oncoprotein carcinogenesis","volume":"745","author":"Chen","year":"2023","journal-title":"Arch Biochem Biophys"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031818","article-title":"Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins","volume":"23","author":"Har\u0119\u017ca","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1590\/0074-02760190405","article-title":"Human papillomavirus type 18 E5 oncoprotein cooperates with E6 and E7 in promoting cell viability and invasion and in modulating the cellular redox state","volume":"115","author":"Hochmann","year":"2020","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"6327","DOI":"10.1038\/s41388-020-01431-8","article-title":"HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers","volume":"39","author":"Ren","year":"2020","journal-title":"Oncogene"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed9070140","article-title":"Identification and Functional Implications of the E5 Oncogene Polymorphisms of Human Papillomavirus Type 16","volume":"9","author":"da Silva-J\u00fanior","year":"2024","journal-title":"Trop Med Infect Dis"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103923","article-title":"Impact of HPV E5 on viral life cycle via EGFR signaling","volume":"139","author":"Ilahi","year":"2020","journal-title":"Microb Pathog"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"e01582","DOI":"10.1128\/JVI.01582-19","article-title":"Human Papillomavirus 16 E5 Inhibits Interferon Signaling and Supports Episomal Viral Maintenance","volume":"94","author":"Scott","year":"2020","journal-title":"J Virol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27041985","article-title":"Role of E5 from HPV16 in the Evasion of the Immune Response","volume":"27","author":"P\u00e9rez-Morales","year":"2026","journal-title":"Int J Mol Sci"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1158\/0008-5472.CAN-19-1771","article-title":"HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer","volume":"80","author":"Miyauchi","year":"2020","journal-title":"Cancer Res"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02176-8","article-title":"PD-1\/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies","volume":"23","author":"Jin","year":"2024","journal-title":"Mol Cancer"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076834","article-title":"A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer","volume":"24","author":"Clusan","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.7150\/ijbs.21635","article-title":"Risk Factors and Preventions of Breast Cancer","volume":"13","author":"Sun","year":"2017","journal-title":"Int J Biol Sci"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s11427-023-2499-2","article-title":"Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K\/Akt\/mTOR pathway","volume":"67","author":"Ganesan","year":"2024","journal-title":"Sci China Life Sci"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2147\/BCTT.S60696","article-title":"PI3K mutations in breast cancer: prognostic and therapeutic implications","volume":"7","author":"Mukohara","year":"2015","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.7150\/jca.37975","article-title":"Inhibition of the PI3K-AKT-mTOR pathway suppresses the adipocyte-mediated proliferation and migration of breast cancer cells","volume":"11","author":"Park","year":"2020","journal-title":"J Cancer"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011088","article-title":"Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer","volume":"22","author":"Pungsrinont","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04841-w","article-title":"Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway","volume":"22","author":"Tufail","year":"2024","journal-title":"J Transl Med"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"x12","DOI":"10.1093\/annonc\/mdz381","article-title":"Efficacy of PI3K inhibitors in advanced breast cancer","volume":"30 Suppl 10","author":"Verret","year":"2019","journal-title":"Ann Oncol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.7150\/jca.26112","article-title":"PI3K\/Akt\/HIF-1\u03b1 signaling pathway mediates HPV-16 oncoprotein-induced expression of EMT-related transcription factors in non-small cell lung cancer cells","volume":"9","author":"Liu","year":"2018","journal-title":"J Cancer"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.virol.2008.09.040","article-title":"E6 variants of human papillomavirus 18 differentially modulate the protein kinase B\/phosphatidylinositol 3-kinase (akt\/PI3K) signaling pathway","volume":"383","author":"Contreras-Paredes","year":"2009","journal-title":"Virology"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/s0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nature13079","article-title":"Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus","volume":"508","author":"Liu","year":"2014","journal-title":"Nature"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s10555-016-9637-x","article-title":"PI3K\/AKT\/mTOR: role in breast cancer progression, drug resistance, and treatment","volume":"35","author":"Guerrero-Zotano","year":"2016","journal-title":"Cancer Metastasis Rev"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.662232","article-title":"AKT Inhibitors: New Weapons in the Fight Against Breast Cancer?","volume":"12","author":"Martorana","year":"2021","journal-title":"Front Pharmacol"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1002\/2211-5463.12987","article-title":"The high-risk HPV E6 proteins modify the activity of the eIF4E protein via the MEK\/ERK and AKT\/PKB pathways","volume":"10","author":"Morales-Garcia","year":"2020","journal-title":"FEBS Open Bio"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10652-5","article-title":"MLXIPL promotes the migration, invasion, and glycolysis of hepatocellular carcinoma cells by phosphorylation of mTOR","volume":"23","author":"Chang","year":"2023","journal-title":"BMC Cancer"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR Signaling in Growth, Metabolism, and Disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-022-00110-2","article-title":"Targeting the PI3K\/AKT\/mTOR and RAF\/MEK\/ERK pathways for cancer therapy","volume":"3","author":"Li","year":"2022","journal-title":"Mol Biomed"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01608-z","article-title":"Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease","volume":"8","author":"Panwar","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094496","article-title":"Identification of a role for the PI3K\/AKT\/mTOR signaling pathway in innate immune cells","volume":"9","author":"Xie","year":"2014","journal-title":"PLoS One"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010173","article-title":"PI3K\/AKT\/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects","volume":"22","author":"Miricescu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.3390\/biology12050672","article-title":"PI3K\/AKT\/mTOR Signaling Pathway in HPV-Driven Head and Neck Carcinogenesis: Therapeutic Implications","volume":"12","author":"Aguayo","year":"2023","journal-title":"Biology (Basel)"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/carcin\/bgw086","article-title":"mTOR inhibition prevents rapid-onset of carcinogen-induced malignancies in a novel inducible HPV-16 E6\/E7 mouse model","volume":"37","author":"Callejas-Valera","year":"2016","journal-title":"Carcinogenesis"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"9398","DOI":"10.1128\/JVI.00974-10","article-title":"The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis","volume":"84","author":"Spangle","year":"2010","journal-title":"J Virol"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"e02323","DOI":"10.1128\/mBio.02323-18","article-title":"Repression of Human Papillomavirus Oncogene Expression under Hypoxia Is Mediated by PI3K\/mTORC2\/AKT Signaling","volume":"10","author":"Bossler","year":"2019","journal-title":"mBio"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1056\/NEJMoa1109653","article-title":"Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer","volume":"366","author":"Baselga","year":"2012","journal-title":"N Engl J Med"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1200\/JCO.19.01027","article-title":"MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and\/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial","volume":"38","author":"Chien","year":"2020","journal-title":"J Clin Oncol"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/annonc\/mdz086","article-title":"BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-population","volume":"30","author":"Turner","year":"2019","journal-title":"Ann Oncol"},{"key":"ref88","doi-asserted-by":"crossref","unstructured":"A Three-subtype Molecular model of Cervical Cancer: Multiple PI3K Pathway inhibitors suppress growth and cooperate with HPV-directed immunotherapy. medRxiv [Preprint]. 2026 [cited 2026 Feb 5]. Available from: https:\/\/doi.org\/10.64898\/2026.01.21.26344562","DOI":"10.64898\/2026.01.21.26344562"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"5040","DOI":"10.1158\/1078-0432.CCR-21-4290","article-title":"A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck","volume":"28","author":"Nathan","year":"2022","journal-title":"Clin Cancer Res"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"Lu Z, Lee J, Liu R, Li J, Wang Y, Tan L. EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation. Mendeley Data; 2018.","DOI":"10.17632\/658dzgyh5d.1"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.canlet.2021.12.003","article-title":"Regulation of the tumor suppressor PTEN in triple-negative breast cancer","volume":"527","author":"Chai","year":"2022","journal-title":"Cancer Lett"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/modpathol.2013.251","article-title":"High EGFR gene copy number predicts poor outcome in triple-negative breast cancer","volume":"27","author":"Park","year":"2014","journal-title":"Mod Pathol"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1038\/sj.onc.1210798","article-title":"High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells","volume":"27","author":"Bottley","year":"2008","journal-title":"Oncogene"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11091027","article-title":"Do or Die: HPV E5, E6 and E7 in Cell Death Evasion","volume":"11","author":"Skelin","year":"2022","journal-title":"Pathogens"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.3390\/v16111731","article-title":"Immune Response Modulation by HPV16 Oncoproteins in Lung Cancer: Insights from Clinical and In Vitro Investigations","volume":"16","author":"S\u00e3o","year":"2024","journal-title":"Viruses"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a036152","article-title":"Structural Mechanisms of PTEN Regulation","volume":"10","author":"Masson","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.559543","article-title":"HPV 16 E6\/E7 Promote the Glucose Uptake of GLUT1 in Lung Cancer Through Downregulation of TXNIP Due to Inhibition of PTEN Phosphorylation","volume":"10","author":"Tang","year":"2020","journal-title":"Front Oncol"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.21873\/anticanres.14656","article-title":"Significance of","volume":"40","author":"DE","year":"2020","journal-title":"Anticancer Res"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-26622-9","article-title":"Decoding the relationships among miRNA, HPV infection, and tumor suppressor gene expression in breast cancer patients","volume":"15","author":"Naderi","year":"2025","journal-title":"Sci Rep"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1593\/neo.13432","article-title":"Improved clearance during treatment of HPV-positive head and neck cancer through mTOR inhibition","volume":"15","author":"Coppock","year":"2013","journal-title":"Neoplasia"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1038\/s41416-020-0834-6","article-title":"Emerging role of PTEN loss in evasion of the immune response to tumours","volume":"122","author":"Vidotto","year":"2020","journal-title":"Br J Cancer"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007835","article-title":"Autocrine STAT3 activation in HPV positive cervical cancer through a virus-driven Rac1-NF\u03baB-IL-6 signalling axis","volume":"15","author":"Morgan","year":"2019","journal-title":"PLoS Pathog"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0361-x","article-title":"The role of the PI3K\/Akt\/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses","volume":"14","author":"Zhang","year":"2015","journal-title":"Mol Cancer"}],"container-title":["Exploration of Targeted Anti-tumor Therapy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:52:20Z","timestamp":1785891140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.explorationpub.com\/Journals\/etat\/Article\/1002391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":103,"URL":"https:\/\/doi.org\/10.37349\/etat.2026.1002391","archive":["Portico","Portico"],"relation":{},"ISSN":["2692-3114"],"issn-type":[{"value":"2692-3114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"2026-01-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-04","order":2,"name":"published","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"1002391"}}